The adjusted International Prognostic Index and beta-2-microglobulin predict the outcome after autologous stem cell transplantation in relapsing/refractory peripheral T-cell lymphoma Rodríguez J, Conde E, Gutiérrez A, Lahuerta JJ, Arranz R, Sureda A, Zuazu J, Fernández de Sevilla A, Bendandi M, Solano C, León A, Varela MR, Caballero D, Grupo Español de Linfomas/Trasplante Autólogo de Medula Osea, Spanish Lymphoma/Autologous Bone Marrow Transplant Study Group. Haematologica 92(8):1067-74. FI: 6.416 (Q1) Rituximab, gemcitabine and oxaliplatin: an effective regimen in patients with refractory and relapsing mantle cell lymphoma Rodríguez J, Gutierrez A, Palacios A, Navarrete M, Blancas I, Alarcón J, Caballero D, De Mattos SF, Gines J, Martínez J, Lopez A. Leukemia & Lymphoma 48(11):2172-8. FI: 2.397 (Q3) Nephrotic syndrome resulting from focal segmental glomerulosclerosis in a peripheral blood stem cell transplant patient Heras M, Saiz A, Sánchez R, Fernandez-Reyes MJ, Mampaso F, Queizán JA, Molina A, Orfao A, Alvarez-Ude F. Journal of Nephrology 20(4):495-8. FI: 1.252 (Q3) Short-term endothelial progenitor cell colonies are composed of monocytes and do not acquire endothelial markers López-Holgado N, Alberca M, Sánchez-Guijo F, Villarón E, Almeida J, Martín A, Armellini A, García C, Blanco B, Sánchez-Abarca I, Martín S, Pérez-Simón JA, García-Sanz R, San Miguel JF, del Cañizo MC. Cytotherapy 9(1):14-22. FI: 2.204 (Q2) In leukapheresis products from non-Hodgkin¿s lymphoma patients, the immature hematopoietic progenitors show higher CD90 and CD34 antigenic expression Villarón EM, Almeida J, Lopez-Holgado N, Sánchez-Guijo FM, Alberca M, Blanco B, Sánchez-Abarca LI, Lopez O, Pérez-Simón JA, San Miguel JF, del Cañizo MC. Transfusion and Apheresis Science 37(2):145-56. FI: 0.938 (Q4) Molecular characterization of complete and incomplete immunoglobulin heavy chain gene rearrangements in hairy cell leukemia Martín-Jiménez P, García-Sanz R, González D, Balanzategui A, Pérez JJ, Caballero D, Sarasquete ME, Galende J, Orfao A, López-Berges MC, San Miguel JF, González M. Clinical Lymphoma & Myeloma 7(9):573-9. FI: 1.130 (Q4) New criteria to identify risk of progression in smoldering multiple myeloma based on multiparameter flow cytometry analysis of bone marrow plasma cells Perez-Persona E, Vidriales MB, Mateo G, Garcia Sanz R, Mateos MV, Garcia de Coca A, Galende J, Martín-Nunez G, Alonso JM, Heras N, Hernández JM, Martín A, Lopez-Berges C, Orfao A, San Miguel JF. Blood 110(7):2586-92. FI: 10.555 (Q1) Reduced-intensity conditioning compared with conventional allogeneic stem-cell transplantation in relapsed or refractory Hodgkin¿s lymphoma: an analysis from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation Sureda A, Robinson S, Canals C, Carella AM, Boogaerts MA, Caballero D, Hunter AE, Kanz L, Slavin S, Cornelissen JJ, Gramatzki M, Niederwieser D, Russell NH, Schmitz N. Journal of Clinical Oncology 26(3):455-62. FI: 17.793 (Q1) Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survival Valcárcel D, Martino R, Caballero D, Martín J, Ferra C, Nieto JB, Sampol A, Bernal MT, Piñana JL, Vázquez L, Ribera JM, Besalduch J, Moraleda JM, Carrera D, Brunet MS, Pérez-Simón JA, Sierra J. Journal of Clinical Oncology 26(4):577-84. FI: 17.793 (Q1) Allogeneic hematopoietic stem-cell transplantation for chronic lymphocytic leukemia with 17p deletion: a retrospective European Group for Blood and Marrow Transplantation analysis Schetelig J, van Biezen A, Brand R, Caballero D, Martino R, Itala M, García-Marco JA, Volin L, Schmitz N, Schwerdtfeger R, Ganser A, Onida F, Mohr B, Stilgenbauer S, Bornhäuser M, de Witte T, Dreger P. Journal of Clinical Oncology 26(31):5094-100. FI: 17.793 (Q1)
|
